Arrhythmia Alliance News & Events
Arrhythmia Alliance, Bluffton firefighters celebrate new public AED placement
The event will take place at 10:30 a.m. and is a part of the #BlufftonHeartsMatter campaign that aims to place 30 AEDs in the town to create a safer ...
New patient survey results show 80% of AF patients say ‘YES’ to the freedom that INR self-monitoring gives them
The purpose of this survey was to help discover patient thoughts and opinions about INR self-monitoring versus clinic visits. Several trials have demonstrated that patient self-monitoring (PSM) by those on long term warfarin significantly improves time in therapeutic range (TTR) and leads to better management outcomes.
Arrhythmia Alliance Launches APPG-A
Arrhythmias are a critical health concern in the UK, but the necessary policy attention and resource focus is limited. There are many issues from a management and service provision perspective that need to be addressed for the benefit of patients and the NHS. A strong political voice is necessary to help raise these issues and help to effect positive change.
Combination of principal component analysis and optical-flow motion compensation for improved cardiac MR thermometry
The use of magnetic resonance (MR) thermometry for the monitoring of thermal ablation is rapidly expanding. However, this technique remains challenging for the monitoring of the treatment of cardiac arrhythmia by radiofrequency ablation due to the heart displacement with respiration and contraction. Recent studies have addressed this problem by compensating in-plane motion in real-time with optical-flow based tracking technique.
AliveCor launches smallest single lead medical grade ECG, Kardia Band
AliveCor announces the availability of Kardia Band, the world’s smallest single lead medical grade ECG. Kardia Band works with Apple Watch to provide a single lead medical grade ECG of the user’s heart rhythm to identify possible Atrial Fibrillation - a leading cause of AF-related stroke in the UK.
58 Year Old Saved By Bluffton Police Department Using AED donated by Arrhythmia Alliance Defibs Saves Lives – Gavin Quance Campaign
October 26th , 2016, Hilton Head Island, South Carolina: Arrhythmia Alliance, a leading international heart rhythm charity based in South Carolina, is pleased to announce that a 58-year old male was saved yesterday by the Bluffton Police Department by one of the defibrillators that was recently placed in the vehicles from the Arrhythmia Alliance – Defibs Save Lives – Gavin Quance Campaign. Officers responded to a report of a 58 year old male who had collapsed. Upon arrival, ahead of paramedics, the officers perfomed CPR and used the AED from the vehicle. After two shocks, they brought the person back. He was breathing and is currently being treated at Hilton Head Hospital.
Arrhythmia Alliance Medical Director Named President Elect of British Heart Rhythm Society
Friday 21 October, Birmingham, UK: Arrhythmia Alliance is pleased to announce that its Medical Director, Professor Richard Schilling, St Bartholomew’s Hospital, London has been chosen as the next President of the British Heart Rhythm Society – the world’s first heart rhythm society established in 1976. This further reinforces the strong links between the UK’s leading Heart Rhythm Charity and the Cardiac Specialists professional organization, combining the voice of the patient with that of the physician.
Arrhythmia Alliance places 3000th Public Access Defibrillator on World Restart the Heart Day
“AEDs must be as commonplace as fire extinguishers and smoke alarms if we are to dramatically reduce the number of deaths from sudden cardiac arrest in the UK.”
ARRHYTHMIA ALLIANCE PLACES 3000TH PUBLIC ACCESS DEFIBRILLATOR ON WORLD RE-START THE HEART DAY
New real-world analysis reports lower risk of major bleeding with dabigatran compared to rivaroxaban in stroke prevention
Ingelheim, Germany, 13.October 2016 – A large observational study by researchers from the U.S. FDA has found that dabigatran (150 mg twice daily) was associated with lower rates of intracranial haemorrhage and major extracranial bleeding, including major gastrointestinal bleeding than rivaroxaban (20 mg once daily) in patients with atrial fibrillation (AF). The study is the largest observational study to-date comparing the two drugs, and analysed data from over 118,000 AF patients. Based on the data published in JAMA Internal Medicine, the accompanying Editor’s Note written by Parks and Redberg suggests that physicians should “prescribe dabigatran over rivaroxaban for patients with atrial fibrillation.”